Moderna Inc (MIL:1MRNA)
€ 38.165 -0.445 (-1.15%) Market Cap: 14.61 Bil Enterprise Value: 9.32 Bil PE Ratio: 0 PB Ratio: 1.30 GF Score: 44/100

Moderna Inc at Cowen Health Care Conference Transcript

Mar 06, 2023 / 02:10PM GMT
Tyler Martin Van Buren
Cowen and Company, LLC, Research Division - MD & Senior Equity Research Analyst

Okay. Great. Well, let's go ahead and keep going. Good morning, everyone. Tyler Van Buren here, Senior Biotech Analyst at TD Cowen. And for this first far-side chat, it's my pleasure to introduce Stephen Hoge, President of Moderna. Thank you very much for being here Stephen.

Stephen Hoge
Moderna, Inc. - President

Thank you, Tyler. It's exciting.

Questions & Answers

Tyler Martin Van Buren
Cowen and Company, LLC, Research Division - MD & Senior Equity Research Analyst

So before I get it started, for the audience, if you guys have questions, feel free to raise your hands as well. And we'll plan to dig in most R&D questions (technical difficulty) I wanted to kick it off with the commercial one. On COVID, you guys have talked about $5 billion in deliveries for 2023, maybe around $2 billion in the first half, $3 billion in the second half. Can you just discuss your confidence in that number and

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot